Merck Tbk PT

Merck Tbk PT EBIT Margin

The EBIT Margin (Operating Margin) of Merck Tbk PT (MERK.JK) as of Oct 16, 2026 is 26.69 %. In the previous year, EBIT Margin (Operating Margin) was 18.61 % — a change of 43.39% (higher).

EBIT Margin

26.69 %

YoY

43.39%

Last updated:

EBIT Margin (Operating Margin) of Merck Tbk PT is 2025 26.69 % . EBIT Margin (Operating Margin) of Merck Tbk PT was 2024 18.61 % . It decreases by 43.39% higher compared to the previous year.

For Merck Tbk PT, the operating (EBIT) margin of 26.7% is up versus 18.0% a few years ago.

The Merck Tbk PT EBIT Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT Margin
Date
EBIT Margin
Jan 1, 2018
7.70 IDR
Jan 1, 2019
16.87 IDR
Jan 1, 2020
16.55 IDR
Jan 1, 2021
17.99 IDR
Jan 1, 2022
21.26 IDR
Jan 1, 2023
20.77 IDR
Jan 1, 2024
18.61 IDR
Jan 1, 2025
26.69 IDR
The Merck Tbk PT EBIT Margin history
YEAREBIT MarginYoY
26.69 %+43.39%
18.61 %-10.41%
20.77 %-2.28%
21.26 %+18.14%
17.99 %+8.73%
16.55 %-1.89%
16.87 %+119.01%
7.70 %-57.28%
18.03 %-12.55%
20.61 %+8.68%
18.97 %-18.32%
23.22 %+11,952.32%
0.19 %+26.83%
0.15 %-49.92%
0.30 %+56.18%
0.19 %-27.55%
0.27 %+21.88%
0.22 %-2.80%
0.23 %-7.68%
0.25 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Merck Tbk PT Stock analysis

What does Merck Tbk PT do? Merck Tbk PT is a pharmaceutical company based in Jakarta Timur, DKI Jakarta, operating within the Health Care sector. The company, listed on the Indonesian stock exchange with ticker MERK.JK and ISIN ID1000136609, has been publicly traded since its IPO on July 23, 1981. It employs 376 full-time staff and focuses on the development and distribution of pharmaceutical and chemical products. The company operates through three business segments: Biopharma, which covers ethical pharmaceutical products; Consumer Health, which includes over-the-counter products; and Others, which encompasses additional business activities. Merck Tbk PT is committed to providing personalized treatments for serious diseases and supports initiatives related to reproductive health, including enabling individuals to achieve their goal of becoming parents. The company's official website is https://www.merckgroup.com/id-id, where further information about its operations and services can be accessed. As a publicly listed entity, Merck Tbk PT is subject to regulatory disclosures and financial reporting requirements in Indonesia. The company's primary focus remains on delivering healthcare solutions through its pharmaceutical and chemical offerings, targeting both professional medical markets and consumer health needs. Merck Tbk PT is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Merck Tbk PT stock

EBIT Margin (Operating Margin) of Merck Tbk PT is 26.69 % in 2025.

EBIT Margin (Operating Margin) of Merck Tbk PT changed from 18.61 % to 26.69 %, representing a 43.39% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBIT Margin (Operating Margin) Merck Tbk PT since 2006 – with annual values, charts, and detailed analysis.

EBIT Margin measures operating profitability as a percentage of revenue. It shows how much profit a company makes from operations before interest and taxes.

A 'good' varies by industry and company stage. On Eulerpool, you can compare EBIT Margin (Operating Margin)'s Merck Tbk PT with sector peers and the industry average to assess whether it is attractive.

To evaluate EBIT Margin (Operating Margin)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EBIT Margin (Operating Margin).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Margins — Merck Tbk PT

Gross MarginEBIT MarginEBITDA MarginNet MarginFCF MarginR&D / RevenueTax RatePayout RatioPre-Tax MarginOCF MarginSGA/RevenueOpEx/RevenueReinvestment Rate

All Key Metrics — Merck Tbk PT